XENIA HOTELS & RESORTS INC (XHR)

US9840171030 - REIT

15.02  -0.93 (-5.83%)

After market: 15.02 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to XHR. XHR was compared to 130 industry peers in the Diversified REITs industry. XHR may be in some trouble as it scores bad on both profitability and health. XHR does not seem to be growing, but still is valued expensively.



3

1. Profitability

1.1 Basic Checks

XHR had positive earnings in the past year.
In the past year XHR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: XHR reported negative net income in multiple years.
XHR had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

XHR's Return On Assets of 0.83% is in line compared to the rest of the industry. XHR outperforms 53.91% of its industry peers.
XHR's Return On Equity of 1.90% is in line compared to the rest of the industry. XHR outperforms 52.34% of its industry peers.
With a Return On Invested Capital value of 2.47%, XHR perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
Industry RankSector Rank
ROA 0.83%
ROE 1.9%
ROIC 2.47%
ROA(3y)-0.73%
ROA(5y)-1.16%
ROE(3y)-1.57%
ROE(5y)-2.41%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Profit Margin value of 2.33%, XHR perfoms like the industry average, outperforming 44.53% of the companies in the same industry.
XHR's Profit Margin has declined in the last couple of years.
XHR has a worse Operating Margin (8.35%) than 85.16% of its industry peers.
XHR's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 54.35%, XHR is not doing good in the industry: 76.56% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of XHR has remained more or less at the same level.
Industry RankSector Rank
OM 8.35%
PM (TTM) 2.33%
GM 54.35%
OM growth 3YN/A
OM growth 5Y-4.65%
PM growth 3YN/A
PM growth 5Y-36.78%
GM growth 3Y13.94%
GM growth 5Y-1.03%

3

2. Health

2.1 Basic Checks

XHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, XHR has less shares outstanding
XHR has less shares outstanding than it did 5 years ago.
XHR has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.74, we must say that XHR is in the distress zone and has some risk of bankruptcy.
XHR has a Altman-Z score (0.74) which is comparable to the rest of the industry.
The Debt to FCF ratio of XHR is 54.20, which is on the high side as it means it would take XHR, 54.20 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of XHR (54.20) is comparable to the rest of the industry.
XHR has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
XHR has a Debt to Equity ratio (1.10) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 54.2
Altman-Z 0.74
ROIC/WACC0.35
WACC6.95%

2.3 Liquidity

XHR has a Current Ratio of 1.31. This is a normal value and indicates that XHR is financially healthy and should not expect problems in meeting its short term obligations.
XHR has a Current ratio of 1.31. This is comparable to the rest of the industry: XHR outperforms 55.47% of its industry peers.
XHR has a Quick Ratio of 1.31. This is a normal value and indicates that XHR is financially healthy and should not expect problems in meeting its short term obligations.
XHR has a Quick ratio (1.31) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31

3

3. Growth

3.1 Past

XHR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -43.90%.
XHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -33.93% yearly.
XHR shows a decrease in Revenue. In the last year, the revenue decreased by -0.45%.
The Revenue has been decreasing by -0.63% on average over the past years.
EPS 1Y (TTM)-43.9%
EPS 3YN/A
EPS 5Y-33.93%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-0.45%
Revenue growth 3Y40.49%
Revenue growth 5Y-0.63%
Sales Q2Q%2.06%

3.2 Future

Based on estimates for the next years, XHR will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.97% on average per year.
XHR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.82% yearly.
EPS Next Y11.4%
EPS Next 2Y30.69%
EPS Next 3Y10.97%
EPS Next 5YN/A
Revenue Next Year1.64%
Revenue Next 2Y3.14%
Revenue Next 3Y2.82%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 65.30, XHR can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of XHR is on the same level as its industry peers.
XHR is valuated expensively when we compare the Price/Earnings ratio to 28.77, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 51.73, XHR can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of XHR indicates a somewhat cheap valuation: XHR is cheaper than 61.72% of the companies listed in the same industry.
XHR is valuated expensively when we compare the Price/Forward Earnings ratio to 23.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 65.3
Fwd PE 51.73

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, XHR is valued a bit cheaper than 64.06% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as XHR.
Industry RankSector Rank
P/FCF 59.4
EV/EBITDA 13.4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.73
PEG (5Y)N/A
EPS Next 2Y30.69%
EPS Next 3Y10.97%

2

5. Dividend

5.1 Amount

XHR has a Yearly Dividend Yield of 2.99%.
XHR's Dividend Yield is slightly below the industry average, which is at 15.68.
XHR's Dividend Yield is a higher than the S&P500 average which is at 2.24.
Industry RankSector Rank
Dividend Yield 2.99%

5.2 History

The dividend of XHR decreases each year by -17.85%.
XHR has been paying a dividend for over 5 years, so it has already some track record.
The dividend of XHR decreased recently.
Dividend Growth(5Y)-17.85%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

192.33% of the earnings are spent on dividend by XHR. This is not a sustainable payout ratio.
DP192.33%
EPS Next 2Y30.69%
EPS Next 3Y10.97%

XENIA HOTELS & RESORTS INC

NYSE:XHR (12/18/2024, 4:33:32 PM)

After market: 15.02 0 (0%)

15.02

-0.93 (-5.83%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.53B
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield 2.99%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 65.3
Fwd PE 51.73
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)5.73
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.83%
ROE 1.9%
ROCE
ROIC
ROICexc
ROICexgc
OM 8.35%
PM (TTM) 2.33%
GM 54.35%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-43.9%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y11.4%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-0.45%
Revenue growth 3Y40.49%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y